Snowball Research
Research hub for stocks under $5B
⌘K
Subscribe Sign in
paid-only post activistcompany

ADAR1 Demands Keros Therapeutics (KROS)Reopen Board Nominations, Citing Governance Breaches

This post is for paying subscribers only

Subscribe to continue reading


More like this

Trium Capital Rejects Acelyrin (SLRN)-Alumis Merger, Urges Liquidation Instead

Galloway Opposes WW International, Inc (WW) Rumored Bankruptcy, Urges Debt Restructuring

Outerbridge Capital reaches agreement with Barnes & Noble Education (BNED)

Value Base Ltd Opposes Poison Pill, Citing Shareholder Harm at Perion Network Ltd (PERI)

Engine Capital Nominates Directors to Push for Change at Lyft (LYFT)

Woodbridge Nominates Two Directors to Replace Retiring Thomson Reuters (TRI) Board Member